Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aridis Pharmaceuticals Inc (ARDS)

Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aridis Pharmaceuticals Inc 983 University Avenue Bldg. B Los Gatos CA 95032 USA

www.aridispharma.com P: 408-385-1742

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Aridis Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. The company's product pipeline consists of AR-301, AR-105, AR-101, AR-401, AR-201 and AR-501 which are in clinical stages. Aridis Pharmaceuticals, Inc. is based in San Jose, United States.

Key Statistics

Overview:

Market Capitalization, $K 133
Enterprise Value, $K -4,927
Shares Outstanding, K 53,321
Float, K 50,388
% Float 94.50%
Short Interest, K 26
Short Float 0.05%
Days to Cover 1.42
Short Volume Ratio 0.00
% of Insider Shareholders 5.50%
% of Institutional Shareholders 9.65%

Financials:

Annual Sales, $ 3,090 K
Annual Net Income, $ -30,370 K
Last Quarter Sales, $ 420 K
Last Quarter Net Income, $ -80 K
EBIT, $ -880 K
EBITDA, $ -390 K

Growth:

1-Year Return 2,400.00%
3-Year Return -99.75%
5-Year Return -99.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/06/25
Earnings Per Share ttm -0.18
EPS Growth vs. Prev Year -62.80%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ARDS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -982.85%
Debt/Equity 0.00
Price/Sales 0.01
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.26
Interest Coverage -3.24
60-Month Beta 49.67
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar